BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao J, Hou D, Hu P, Mao G. Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt/β-catenin signaling. Transl Cancer Res 2021;10:2437-50. [PMID: 35116559 DOI: 10.21037/tcr-21-689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yu YH, Zhang HJ, Yang F, Xu L, Liu H. Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway. J Ethnopharmacol 2023;310:116311. [PMID: 36894110 DOI: 10.1016/j.jep.2023.116311] [Reference Citation Analysis]
2 Yang Z, Sun Q, Wang S, Tang B, Yuan C, Wu Y, Dai J, Yang C, Wang L, Zhou Q, Wang J, Weng Q. Pharmacokinetics, tissue distribution, and plasma protein binding rate of curcumol in rats using liquid chromatography tandem mass spectrometry. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1036732] [Reference Citation Analysis]
3 Li J, Peng P, Lai KP. Therapeutic targets and functions of curcumol against COVID-19 and colon adenocarcinoma. Front Nutr 2022;9:961697. [PMID: 35967794 DOI: 10.3389/fnut.2022.961697] [Reference Citation Analysis]
4 Koliqi R, Grapci AD, Selmani PB, Uskoković V. Gene Expression Effects of the Delivery of SN-38 via Poly(D-L-lactide-co-caprolactone) Nanoparticles Comprising Dense and Collapsed Poloxamer Coronae. J Pharm Innov. [DOI: 10.1007/s12247-022-09672-8] [Reference Citation Analysis]
5 Wang J, Jin J, Chen T, Zhou Q. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages. Molecules 2022;27:4345. [DOI: 10.3390/molecules27144345] [Reference Citation Analysis]